VitMode

Dark Chocolate and Your Heart: How Much Do You Actually Need to Eat?

The flagship COSMOS trial of over 21,000 people found daily cocoa flavanol supplementation didn't significantly cut total cardiovascular events — but it did cut cardiovascular deaths by 27%. A separate dose-response meta-analysis shows the vascular benefit peaks at around 700 mg of flavanols a day — far more than a typical bar of dark chocolate delivers, and one that doesn't keep improving with an even higher dose.

AKdr Anna KowalczykAugust 23, 202612 min read
Table of contents

Why this question is more complex than it looks

"Dark chocolate is good for your heart" is one of those popular claims that's circulated in public discourse long enough that almost no one asks about the details — exactly how much you need to eat, what effect studies actually observe, and whether it applies to all hard endpoints or only some.

The answer given by two independent data sources — one large randomized trial and one dose-response meta-analysis — is more nuanced than a simple "yes" or "no." This is a story about dose mattering more than the popular marketing message suggests, not a simple tale of chocolate being a miracle cure or being entirely useless.

What the flagship COSMOS trial found

The most important data source on this topic is the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) — one of the largest randomized trials testing cocoa flavanol supplementation against hard cardiovascular endpoints, published in 2022 in the American Journal of Clinical Nutrition.

Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS)

Strong evidence

Sesso HD, Manson JE, Aragaki AK, et al. · American Journal of Clinical Nutrition · 2022

This randomized trial covered 21,442 US adults (women aged 65+, men aged 60+), who received either 500 mg of cocoa flavanols a day (including 80 mg of epicatechin) or a placebo. Total cardiovascular events numbered 410 in the cocoa group vs. 456 in the placebo group (HR=0.90; 95% CI 0.78-1.02; P=0.11) — a statistically non-significant difference. Cardiovascular deaths specifically, however, were significantly lower in the cocoa group: HR=0.73 (95% CI 0.54-0.98), a 27% reduction. A per-protocol analysis (excluding people who dropped out early) showed HR=0.85 (95% CI 0.72-0.99) for total cardiovascular events — a borderline-significant result.

View study

A gap between the main endpoint and cardiovascular deaths

Moderate evidence

This is one of those rare cases where a trial's main, pre-specified endpoint (total cardiovascular events) fell short of statistical significance, while a secondary endpoint (cardiovascular deaths) showed a clear, significant effect. This pattern calls for careful interpretation — it's not as strong evidence as a significant result on the main endpoint would be, but it can't be dismissed either, especially since the per-protocol analysis came close to statistical significance for the main endpoint too.

What the dose-response meta-analysis shows

The second key piece of the puzzle is the question of dose — how much cocoa flavanols does it take to get a measurable vascular effect? This is answered by the 2019 meta-analysis by Sun and colleagues, published in Food & Function, focused on endothelial function (FMD, flow-mediated dilation) as a biomarker of blood vessel health.

Dose-response relationship between cocoa flavanols and human endothelial function: a systematic review and meta-analysis of randomized trials

Moderate evidence

Sun Y, Zimmermann D, De Castro CA, Actis-Goretta L · Food & Function · 2019

The meta-analysis covered 15 studies (18 study arms), with flavanol doses ranging from 80-1,248 mg above the control group (mean 704 mg). Overall FMD improvement (endothelial function) was 1.17 percentage points (95% CI 0.76-1.57). The dose-response relationship followed a non-linear, inverted-U shape — the optimal effect was observed at around 710 mg total flavanols / 95 mg epicatechin / 25 mg catechin, meaning that above this range, more flavanols didn't translate into further improvement.

View study

A typical chocolate bar delivers far less than this optimal range

Moderate evidence

The optimal dose identified in this meta-analysis (around 700 mg of flavanols) is far higher than the flavanol content of a typical serving of store-bought dark chocolate, which — depending on the manufacturer and how the cocoa was processed — usually delivers much smaller amounts. This is important practical context: a "dark chocolate, high cocoa content" label alone doesn't guarantee a given serving approaches the dose tested in these studies.

Why this is neither "chocolate cures your heart" nor "chocolate doesn't matter"

Putting these two studies together gives a picture more complex than popular headlines suggest. COSMOS didn't confirm an effect on its main, hardest endpoint (total cardiovascular events), but it did show a significant 27% drop in cardiovascular deaths. The Sun et al. meta-analysis, in turn, shows the vascular-level effect is real, but dose-dependent — and that dose is higher than a typical serving of consumer chocolate delivers.

Myth

Dark chocolate is simply good for your heart — the more cocoa on the label, the greater the benefit, regardless of how much chocolate you actually eat.

Fact

The data suggests something more nuanced: COSMOS tested a concentrated flavanol supplement (500 mg/day), not ordinary chocolate, and didn't confirm an effect on total cardiovascular events, though it did show a drop in cardiovascular deaths. The dose-response meta-analysis, meanwhile, shows the vascular benefit rises up to a certain threshold (around 700 mg) and doesn't increase beyond it — more isn't always better, and a typical chocolate bar usually doesn't deliver that amount.

It's also worth remembering that store-bought dark chocolate is a completely different product from the concentrated flavanol extract tested in these studies — it also contains sugar and fat, whose amount and quality can partly offset the potential benefits of the flavanols themselves, especially with regular, high consumption.

What this means in practice

Practical takeaways from both studies

  • Dark chocolate alone, in typical store-bought amounts, likely doesn't deliver the flavanol dose tested in COSMOS (500 mg) or the optimal dose from the Sun et al. meta-analysis (around 700 mg)
  • COSMOS didn't confirm an effect on total cardiovascular events, but did show a significant 27% drop in cardiovascular deaths — a promising, but not definitive, result
  • The dose-response relationship for vascular function follows an inverted-U shape — beyond the optimal range, increasing the dose further brings no additional benefit
  • Treating a daily chocolate bar as a guaranteed "heart therapy" has no solid support in this data — at best, it's a potential, modest plus within an otherwise balanced diet
  • Concentrated cocoa flavanol supplements (like those tested in COSMOS) are a different scenario from eating chocolate as a snack, given the differences in dose, sugar, and fat

In practice, this means dark chocolate can be part of a balanced diet, but shouldn't be treated as a substitute for proven cardiac interventions or as guaranteed heart protection — the effect seen in these studies mainly concerned concentrated flavanol supplementation at a specific, higher dose than a typical chocolate serving, not the mere act of eating chocolate.

Limitations worth keeping in mind

What these studies don't prove

COSMOS tested a concentrated flavanol supplement, not chocolate as a food product — the results shouldn't be directly translated into the effect of eating chocolate in a typical form and amount. The trial's main, hardest endpoint (total cardiovascular events) fell short of statistical significance, limiting the strength of the conclusion about cardiac benefit. The Sun et al. meta-analysis relies on a surrogate biomarker (FMD), not hard endpoints like heart attack or death — an improvement in FMD isn't the same as a proven reduction in clinical cardiovascular event risk. Neither study directly evaluated ordinary, store-bought dark chocolate with its full composition (sugar, fat), only isolated flavanols.

Practical summary

QuestionShort answer
Do cocoa flavanols reduce cardiovascular events?COSMOS didn't confirm this for total events, but showed a 27% drop in cardiovascular deaths
How much flavanols gives the optimal vascular effect?Around 700 mg a day, per the dose-response meta-analysis — more doesn't improve the effect further
Does a typical chocolate bar deliver that dose?Usually not — tested doses in these studies are higher than a typical store-bought chocolate serving
Does this mean chocolate is useless for the heart?No — it means the effect depends on dose and form (concentrated supplement vs. ordinary chocolate), not a simple yes or no
How strong is the evidence?Moderate to strong for flavanol supplementation, weaker for extrapolating to ordinary consumer chocolate

Dark chocolate and heart health in brief

Our editorial recommendation

This topic illustrates well why simplified headlines ("chocolate is good for your heart") miss the most important detail — dose. COSMOS and the Sun et al. meta-analysis together suggest a real but modest, and strongly dose-dependent, potential for cocoa flavanols, far from the simple marketing message that a daily chocolate bar is "heart therapy."

If you enjoy dark chocolate, there's no reason to give it up as part of a balanced diet — but it's not worth treating it as guaranteed cardiovascular protection, or as a replacement for proven cardiac recommendations like those described in our Mediterranean diet entry.

Dark chocolate is one of those topics where the truth sits exactly between two extreme headlines — neither a miracle heart drug nor pure marketing fiction, but a modest, dose-dependent effect that's easy to lose in an oversimplified message.

Dr. Anna Kowalczyk, VitMode editorial team

Frequently asked questions

The studies don't give a clear answer about a specific amount of ordinary chocolate — they tested concentrated flavanol supplements (500 mg in COSMOS, an optimal around 700 mg per the dose-response meta-analysis), not standard store-bought chocolate servings, which usually deliver far fewer flavanols than these doses.

A supplement allows precise flavanol dosing without the extra sugar and fat present in chocolate, which is exactly what was tested directly in the COSMOS trial. It's still worth discussing supplementation with a doctor, especially with existing cardiovascular conditions.

This is a common, though carefully-interpreted, pattern in clinical trials — a secondary endpoint (deaths) can show a significant effect while a broader, main endpoint (all cardiovascular events, including non-fatal ones) falls short of statistical significance. This doesn't invalidate the death-related finding, but it does need confirmation in further studies.

Both studies discussed tested cocoa flavanols, whose content is far higher in dark chocolate with a high cocoa content than in milk or white chocolate, where the proportion of cocoa mass is lower or absent. Neither study directly tested a comparison between different types of chocolate.

Sources

AK

dr Anna Kowalczyk

PhD in Molecular Biology (University of Warsaw), 8 years researching cellular aging

Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.

Related articles

Tacka świeżych jajek na białym blacie kuchennym

Eggs and Blood Cholesterol: Does an Egg-Rich Diet Harm Your Heart?

For decades, eggs served as the poster child for a food to "avoid" if you cared about your heart — because of the high cholesterol content in the yolk. The newest, massive analysis combining three prospective US cohorts (215,618 people, followed for up to 32 years) and an updated meta-analysis spanning 1.72 million participants worldwide paints a far calmer picture: eating up to one egg a day shows no significant association with elevated cardiovascular risk. In Asian cohorts, researchers even observed a mild protective effect. This is one of those cases where the scale and quality of newer data shifts conclusions from decades past — not because the old studies were poorly done, but because newer analyses have the statistical power to catch nuances smaller samples couldn't see. In this article, we look at exactly what the numbers show, where certainty ends, and where nuance begins.

11 min

August 24, 2026

Kapsułki oleju rybiego omega-3 w ceramicznej misce

High-Dose Omega-3 and Atrial Fibrillation: An Unexpected Side Effect?

Omega-3 fatty acids have a well-established reputation as an unambiguously heart-healthy supplement. Two independent, large clinical trials evaluating high, prescription-strength omega-3 doses (4g/day) in cardiac patients show a consistent and concerning signal: this therapy meaningfully increases the risk of new-onset atrial fibrillation — an irregular heart rhythm — even in a trial where the same supplement produced a real, measurable cardiovascular benefit. This is not a warning about a typical over-the-counter fish oil supplement, but a specific signal tied to the high doses used to treat hypertriglyceridemia — a distinction that's easy to lose in simplified headlines.

13 min

August 25, 2026

Lekarz notujący szczegóły podczas konsultacji pacjenta w gabinecie

TRT or Lifestyle Change? What Actually Raises Testosterone Before You Consider Therapy

Before considering testosterone replacement therapy, it's worth checking how much sleep, training, and fat loss can realistically achieve — and when these interventions genuinely aren't enough.

7 min

July 29, 2026

Bogaty wybór świeżych składników na stole — różnorodność zdrowych opcji żywieniowych

Keto, DASH, or Mediterranean? Which Approach Has the Strongest Evidence for Weight Loss

We compare three popular eating patterns based on real scientific evidence — not social media popularity — to help you choose the approach that fits your goal.

8 min

July 31, 2026

Related knowledge base entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.